Cargando…

Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?

Detalles Bibliográficos
Autores principales:	Vogel, W, Surowy, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360438/ https://www.ncbi.nlm.nih.gov/pubmed/17848944 http://dx.doi.org/10.1038/sj.bjc.6603977

Ejemplares similares

Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer?
por: Narod, S A
Publicado: (2007)

Undetected hypothyroidism and unexpected anesthetic complications
por: Sudha, P, et al.
Publicado: (2012)

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
por: Kotsopoulos, J, et al.
Publicado: (2007)

Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk
por: Ricks-Santi, Luisel J, et al.
Publicado: (2011)

Effect of the novel Moroccan BRCA1 and BRCA2 frameshift mutations
por: Tazzite, Amal, et al.
Publicado: (2013)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Defective endotracheal tube: Undetected by routine inspection
por: Badamali, Ashok K., et al.
Publicado: (2014)

Difficult ventilation due to an undetected mask crack
por: Kitaura, Atsuhiro, et al.
Publicado: (2023)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
por: Phillips, KA, et al.
Publicado: (2012)

Is BRCA2 involved in early onset colorectal cancer risk?
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2019)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review
por: Bertozzi, Serena, et al.
Publicado: (2023)

Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
por: Park, Joonhong, et al.
Publicado: (2016)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers
por: Rieder, Viktoria, et al.
Publicado: (2015)

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction
por: Tai, Yu Chuan, et al.
Publicado: (2008)

Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'
por: Friedenson, Bernard
Publicado: (2016)

Comment on ‘The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'
por: Paradiso, A V, et al.
Publicado: (2016)

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016)

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ikejima, Kengo, et al.
Publicado: (2023)

Comment on: Endometrial cancer occurrence five years after breast cancer in BRCA2 mutation patient
por: Choi, Min Chul, et al.
Publicado: (2015)

Response to ‘Comments on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study''
por: Narod, Steven A
Publicado: (2016)

Survival in Norwegian BRCA1 mutation carriers with breast cancer
por: Hagen, Anne Irene, et al.
Publicado: (2009)

Management of Breast Cancer in BRCA1/2 Mutation Carriers
por: Eeles, R. A., et al.
Publicado: (1999)

Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
por: Kwong, Ava, et al.
Publicado: (2012)

Analysis of PTEN in two BRCA1 and BRCA2 wild-type familial breast cancer patients
por: Akouchekian, Mansoureh, et al.
Publicado: (2015)

Experience with Bilateral Risk-Reducing Mastectomy for an Unaffected BRCA Mutation Carrier
por: Maeshima, Yurina, et al.
Publicado: (2016)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2005)

PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
por: Annunziata, Christina M, et al.
Publicado: (2010)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
por: McCrorie, Alan D, et al.
Publicado: (2020)

Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ikejima, Kengo, et al.
Publicado: (2023)

Utility of C-Reactive Protein in Febrile Children with Clinically Undetectable Serious Infection
por: Grover, Abhinav, et al.
Publicado: (2013)

Large-scale discovery of previously undetected microRNAs specific to human liver
por: Minatel, Brenda C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9gl2b42kojqk9bui7pib1q3mii